Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer

NCT01852838 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT01852838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01852838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2013
Completion date
April 30, 2015
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer